全文获取类型
收费全文 | 309916篇 |
免费 | 27362篇 |
国内免费 | 18558篇 |
专业分类
耳鼻咽喉 | 2762篇 |
儿科学 | 4148篇 |
妇产科学 | 5354篇 |
基础医学 | 34112篇 |
口腔科学 | 5271篇 |
临床医学 | 39587篇 |
内科学 | 47744篇 |
皮肤病学 | 3524篇 |
神经病学 | 15961篇 |
特种医学 | 11024篇 |
外国民族医学 | 118篇 |
外科学 | 32725篇 |
综合类 | 49491篇 |
现状与发展 | 62篇 |
一般理论 | 55篇 |
预防医学 | 22113篇 |
眼科学 | 8215篇 |
药学 | 31808篇 |
269篇 | |
中国医学 | 16537篇 |
肿瘤学 | 24956篇 |
出版年
2024年 | 1005篇 |
2023年 | 4448篇 |
2022年 | 11090篇 |
2021年 | 14470篇 |
2020年 | 10928篇 |
2019年 | 9483篇 |
2018年 | 9874篇 |
2017年 | 9186篇 |
2016年 | 8595篇 |
2015年 | 13060篇 |
2014年 | 16641篇 |
2013年 | 16159篇 |
2012年 | 23461篇 |
2011年 | 25650篇 |
2010年 | 16903篇 |
2009年 | 13668篇 |
2008年 | 17352篇 |
2007年 | 17345篇 |
2006年 | 16503篇 |
2005年 | 15898篇 |
2004年 | 11123篇 |
2003年 | 9995篇 |
2002年 | 8609篇 |
2001年 | 7523篇 |
2000年 | 7155篇 |
1999年 | 7044篇 |
1998年 | 3958篇 |
1997年 | 4011篇 |
1996年 | 3015篇 |
1995年 | 2756篇 |
1994年 | 2376篇 |
1993年 | 1603篇 |
1992年 | 2378篇 |
1991年 | 2077篇 |
1990年 | 1740篇 |
1989年 | 1531篇 |
1988年 | 1308篇 |
1987年 | 1220篇 |
1986年 | 977篇 |
1985年 | 781篇 |
1984年 | 509篇 |
1983年 | 402篇 |
1982年 | 237篇 |
1981年 | 212篇 |
1980年 | 198篇 |
1979年 | 261篇 |
1978年 | 151篇 |
1977年 | 122篇 |
1976年 | 102篇 |
1974年 | 119篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
Amrik Sahota Min Yang Sujuan Gao Siu L. Hui Olusegun Baiyewu Oyewusi Gureje Steven Oluwole Adesola Ogunniyi Kathleen S. Hall Hugh C. Hendrie 《Annals of neurology》1997,42(4):659-661
As a part of our ongoing study on Alzheimer's disease (AD) in elderly African Americans, we obtained clinical assessment and apolipoprotein E (ApoE) genotype data on 288 individuals (including 60 with AD). The ApoE σ4 allele frequency was significantly increased in AD patients compared with controls. The age-adjusted odds ratio (OR) for AD in σ4 homozygotes was 4.83 (95% confidence interval [CI], 1.71–13.64) compared with the σ3/σ3 genotype, but the OR for AD with the σ3/σ4 genotype did not reach significance (1.20; 95% CI, 0.58–2.45). These findings suggest that the association between ApoE σ4 and AD is weaker in African Americans than in whites. 相似文献
42.
43.
斑点—酶联免疫吸附试验检测卡氏肺孢子虫 总被引:1,自引:0,他引:1
应用完整的卡氏肺孢子虫包囊作抗原,以4×10^7/ml包裹点样,作斑点-酶联免疫吸附试验检测肺印片卡氏肺孢子虫包囊阳性的BALB/c小鼠血清20份,同时检测包囊阴性的小鼠血清20份,结果除一份小鼠血清IgG阴性反应外,均为阳性反应,阳性率为95%;而正常对照血清全为阴性反应。另外,检测了3份纤支镜刷检物中包囊阳性的病人血清,均为阳性反应;50例健康孕妇血清的检查,抗体阳性率为12%。 相似文献
44.
The granulocyte colony-stimulating factor (G-CSF) has been shown to accelerate recovery from severe neutropenia and to decrease the incidence of documented infections after intensive chemotherapy in cancer patients. However, the routine prophylactic use of G-CSF is expensive. This study was conducted to determine the role of G-CSF as adjunct therapy for septicemia following neutropenia caused by chemotherapy in children with acute leukemia. Fifty consecutive episodes of septicemia were studied involving 34 episodes of Gram-negative, 7 episodes of Gram-positive, 5 episodes of polymicrobial bacterial septicemia, one episode of fungemia, and 3 episodes of disseminated fungal infection. In the first 25 episodes, G-CSF was not used (group A). For the next 16 episodes, G-CSF 200 μg per square meter per day subcutaneously was given immediately after the septicemia was documented until the absolute neutrophil count was maintained at more than 1,500 per cubic millimeter (group B). Thereafter, G-CSF at the same dose as that of group B was prophylactically used in all the children who received high-dose cytosine arablnc-side-containing regimens. Nine episodes of septicemia occurred (group C). The incidences of mortality per episode of septicemia in groups A, B, and C were 12.0% (3/25), 12.5% (2/16) and 0% (0/9), respectively. Statistically, there was no difference between the three groups overall and in pair-wise comparisons (all P > 0.5). The durations of G-CSF administration in group B ranged from 6 to 26 days with a median of 12 days and the durations of G-CSF administration in group C ranged from 10 to 23 days with a median of 19 days. With or without G-CSF, there may be no significant difference in the mortality of septicemia following neutropenia caused by chemotherapy in children with acute leukemia. 相似文献
45.
Twenty-two infants of isolated ventricular septal defect with congestive heart failure were fed with lower-sodium content formula-Lonalac (Mead-Johnson) to study the clinical response of treatment for congestive heart failure. There were no significant changes of intake, urinary output, serum sodium, potassium and osmolality before, 2 days and 6 days after Lonalac feeding. The low sodium content formula may feed the infants with congestive heart failure in addition to the traditional anticongestive therapy. 相似文献
46.
Ductal adenoma of the breast 总被引:1,自引:0,他引:1
Ductal adenoma is a recently described benign tumour of the breast that can be mistaken for carcinoma in both frozen and paraffin sections. Such a case is presented. Fortunately a mastectomy was not performed, but the patient did undergo axillary node dissection. Surgeons and pathologists should familiarize themselves with this lesion so that patients do not have to undergo unnecessary mastectomies and axillary node dissections. 相似文献
47.
L Z Wu L H Zeng Q Y Ma Y J Xie Y Z Chen D Z Wu 《Japanese journal of ophthalmology》1988,32(2):236-245
The hereditary characteristics of enzyme deficiency and dermatoglyphics in congenital color blindness (CCB) were studied. We propose that there is a linkage between the two loci on the X-chromosome determining CCB and glucose-6-phosphate dehydrogenase (G6PD), based on our study of a high incidence of G6PD deficiency in 156 male cases with CCB. The CCB gene is closely linked with that of G6PD deficiency from our pedigree investigations. The rise in the frequency of eight or more whorls, the low value of atd angle and the presenting rate of real palmar patterns of the thenar, hypothenar and I, areas presented the hereditary traits of congenital color blindness. 相似文献
48.
Dr. James Hui Ph.D. Dr. Yow-Ming C. Wang Ph.D. Dr. Appavu Chandrasekaran Ph.D. Dr. Douglas R. Geraets Pharm.D. Dr. James H. Caldwell M.D. Dr. Larry W. Robertson Ph.D. Dr. Richard H. Reuning Ph.D. 《Pharmacotherapy》1994,14(5):607-612
Study Objective . To compare digoxin tablets and liquid-filled capsules with respect to excretion of the drug and its metabolites in urine and feces at steady state. Design . A randomized, crossover trial, each period lasting 3 weeks, with no washout period. Setting . A university hospital. Patients . Six patients, five of whom were elderly, with histories of gastrointestinal disorders, such as hypochlorhydria, intestinal bacterial overgrowth, and inflammatory bowel disease. Interventions . The patients received digoxin once/day in either tablet or capsule form for 3 weeks, and then were switched to the other formulation. Total urinary and fecal excretion from the last 3 days of each regimen were analyzed for the drug and metabolites. Measurements and Main Results . No statistically significant differences were found between tablets and capsules in recovery of digoxin or its metabolites in urine or feces (p=0.05). One subject had a 4-fold increase in urinary drug excretion and 50% decrease in fecal excretion after taking the capsules compared with tablets. Intersubject variability in extent and type of metabolite excretion was greater than intrasubject variability. Conclusions . Fecal analyses may be an accurate way to classify patients as formers of digoxin reduction products. 相似文献
49.
50.